Open AccessSuccessful infertility treatment following fertility‐sparing surgery and chemotherapy for ovarian immature teratoma: a case report and a literature review
Author(s) -
Matsushita Hiroshi,
Tani Hirohiko
Publication year - 2011
Publication title -
reproductive medicine and biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.005
H-Index - 22
eISSN - 1447-0578
pISSN - 1445-5781
DOI - 10.1007/s12522-011-0083-8
Subject(s) - medicine , ovulation induction , infertility , gynecology , fertility , live birth , etoposide , reproductive medicine , chemotherapy , pregnancy , germ cell tumors , fertility preservation , obstetrics , ovulation , surgery , population , hormone , environmental health , biology , genetics
Malignant ovarian germ cell tumors (MOGCTs) are highly chemosensitive tumors most commonly found in adolescent girls and young women. However, patients with advanced disease can now be successfully cured with fertility‐sparing surgery and adjuvant chemotherapy, resulting in childbearing. Case A 24‐year‐old nulliparous Japanese woman was diagnosed as having a stage IIIc immature teratoma. After fertility‐sparing surgery, she received four cycles of chemotherapy consisting of cisplatin, etoposide, and pepleomycin. She married at the age of 34, but did not conceive due to sexual dysfunction of her husband. At the age of 38, intrauterine insemination was performed following ovulation induction with clomid and human menopausal gonadotrophin, which resulted in a singleton pregnancy. A healthy female infant was delivered at 38 weeks’ gestation. Conclusion Treatment might sometimes be needed for infertile women with a history of MOGCTs, but further studies are needed to determine whether infertility treatment, including ovulation induction, is appropriate.